Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis

被引:41
作者
Badagliacca, Roberto [1 ]
Rischard, Franz [2 ,3 ]
Papa, Silvia [1 ]
Kubba, Saad [4 ,5 ]
Vanderpool, Rebecca [3 ]
Yuan, Jason X-J [3 ]
Garcia, Joe G. N. [2 ]
Airhart, Sophia [4 ,5 ]
Poscia, Roberto [1 ]
Pezzuto, Beatrice [1 ]
Manzi, Giovanna [1 ]
Miotti, Cristiano [1 ]
Luongo, Federico [1 ]
Scoccia, Gianmarco [1 ]
Sciomer, Susanna [1 ]
Torre, Roberto [1 ]
Fedele, Francesco [1 ]
Vizza, Carmine Dario [1 ]
机构
[1] Sapienza Univ Rome, Dept Cardiovasc & Resp Sci, Rome, Italy
[2] Univ Arizona, Dept Med, Div Pulm & Crit Care, Tucson, AZ USA
[3] Univ Arizona, Dept Med, Div Cardiol, Tucson, AZ USA
[4] Univ Arizona, Dept Med, Div Translat, Tucson, AZ USA
[5] Univ Arizona, Dept Med, Div Regenerat Med, Tucson, AZ USA
关键词
pulmonary arterial hypertension; right ventricle; echocardiography; cluster analysis; prognosis; risk assessment; RIGHT HEART; COMBINATION THERAPY; FAILURE; ECHOCARDIOGRAPHY; GUIDELINES; DISEASE;
D O I
10.1016/j.healun.2019.12.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: >Despite advances in drug development, life expectancy in idiopathic pulmonary arterial hypertension (IPAH) remains unacceptable. Contemporary IPAH characterization is based on criteria that may not adequately capture disease heterogeneity and may be proposed as a possible explanation for why patient outcome is still unfavorable. The aim of this study was to apply cluster analysis to improve phenotyping of patients with IPAH and analyze long-term clinical outcome of derived clusters. METHODS: Patients with IPAH from 2 referral centers (n = 252) were evaluated with clinical, hemodynamic, and echocardiographic assessment and cardiopulmonary exercise test. Patients were classified according to cluster analysis and followed for clinical worsening occurrence. RESULTS: The cluster analysis identified 4 IPAH phenotypes. Cluster 1 was characterized by young patients, mild pulmonary hypertension (PH), mild right ventricular (RV) dilation and high oxygen (O-2) pulse; Cluster 2 by severe PH and RV dilation and high O-2 pulse; and Cluster 3 by male patients, severe PH and RV dilation, and low O-2 pulse. Cluster 4 patients were older and overweight, with mild PH and RV dilation and low O-2 pulse. After a mean follow-up of 995 +/- 623 days, 123 (48.8%) patients had clinical worsening. Cluster 1 patients presented the best prognosis, whereas Cluster 3 had the highest rates of clinical worsening. Compared with Cluster 1, risk of clinical worsening ranged from 4.12 (confidence interval [CI] 1.43-11.92; p = 0.009) for Cluster 4 to 7.38 (CI 2.80-19.40) for Cluster 2 and 13.8 (CI 5.60-34.0; p = 0.0001) for Cluster 3. CONCLUSIONS: Cluster analysis of clinical variables identified 4 distinct phenotypes of IPAH. Our findings underscore the high degree of disease heterogeneity that exists within patients with IPAH and the need for advanced clinical testing to define phenotypes to improve treatment strategy decision-making. CONDENSED ABSTRACT Idiopathic pulmonary arterial hypertension (IPAH) characterization is based on criteria that may not adequately capture disease heterogeneity. The aim of this study was to apply cluster analysis to improve phenotyping of IPAH. Patients with IPAH (n = 252) were evaluated with clinical, hemodynamic, and echocardiographic assessment and cardiopulmonary exercise test. Within the umbrella category of IPAH, it was the combination of mean pulmonary arterial pressure, right ventricular size, and oxygen pulse that further stratified patients into novel IPAH phenotypes that significantly associate with clinical worsening. These findings underscore the need for novel multidimensional IPAH phenotyping for improved patient care and trial quality. (C) 2020 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:310 / 320
页数:11
相关论文
共 43 条
[1]   Clinical Implications of Chronic Heart Failure Phenotypes Defined by Cluster Analysis [J].
Ahmad, Tariq ;
Pencina, Michael J. ;
Schulte, Phillip J. ;
O'Brien, Emily ;
Whellan, David J. ;
Pina, Ileana L. ;
Kitzman, Dalane W. ;
Lee, Kerry L. ;
O'Connor, Christopher M. ;
Felker, G. Michael .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (17) :1765-1774
[3]   The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension [J].
Badagliacca, Roberto ;
Papa, Silvia ;
Matsubara, Hiromi ;
Lang, Irene Marthe ;
Poscia, Roberto ;
Manzi, Giovanna ;
Vizza, Carmine Dario .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 301 :183-189
[4]   Influence of various therapeutic strategies on right ventricular morphology, function and hemodynamics in pulmonary arterial hypertension [J].
Badagliacca, Roberto ;
Raina, Amresh ;
Ghio, Stefano ;
D'Alto, Michele ;
Confalonieri, Marco ;
Correale, Michele ;
Corda, Marco ;
Paciocco, Giuseppe ;
Lombardi, Carlo ;
Mule, Massimiliano ;
Poscia, Roberto ;
Scelsi, Laura ;
Argiento, Paola ;
Sciomer, Susanna ;
Benza, Raymond L. ;
Vizza, Carmine Dario .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03) :365-375
[5]   Echocardiography Combined With Cardiopulmonary Exercise Testing for the Prediction of Outcome in Idiopathic Pulmonary Arterial Hypertension [J].
Badagliacca, Roberto ;
Papa, Silvia ;
Valli, Gabriele ;
Pezzuto, Beatrice ;
Poscia, Roberto ;
Manzi, Giovanna ;
Giannetta, Elisa ;
Sciomer, Susanna ;
Palange, Paolo ;
Naeije, Robert ;
Fedele, Francesco ;
Vizza, Carmine Dario .
CHEST, 2016, 150 (06) :1313-1322
[6]   Right Intraventricular Dyssynchrony in Idiopathic, Heritable, and Anorexigen-Induced Pulmonary Arterial Hypertension Clinical Impact and Reversibility [J].
Badagliacca, Roberto ;
Reali, Manuela ;
Poscia, Roberto ;
Pezzuto, Beatrice ;
Papa, Silvia ;
Mezzapesa, Mario ;
Nocioni, Martina ;
Valli, Gabriele ;
Giannetta, Elisa ;
Sciomer, Susanna ;
Iacoboni, Carlo ;
Fedele, Francesco ;
Vizza, Carmine Dario .
JACC-CARDIOVASCULAR IMAGING, 2015, 8 (06) :642-652
[7]   Metabolomics enables precision medicine: "A White Paper, Community Perspective" [J].
Beger, Richard D. ;
Dunn, Warwick ;
Schmidt, Michael A. ;
Gross, Steven S. ;
Kirwan, Jennifer A. ;
Cascante, Marta ;
Brennan, Lorraine ;
Wishart, David S. ;
Oresic, Matej ;
Hankemeier, Thomas ;
Broadhurst, David I. ;
Lane, Andrew N. ;
Suhre, Karsten ;
Kastenmueller, Gabi ;
Sumner, Susan J. ;
Thiele, Ines ;
Fiehn, Oliver ;
Kaddurah-Daouk, Rima .
METABOLOMICS, 2016, 12 (09)
[8]   The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension [J].
Benza, Raymond L. ;
Gomberg-Maitland, Mardi ;
Miller, Dave P. ;
Frost, Adaani ;
Frantz, Robert P. ;
Foreman, Aimee J. ;
Badesch, David B. ;
McGoon, Michael D. .
CHEST, 2012, 141 (02) :354-362
[9]   Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice [J].
Berry, Natalia C. ;
Manyoo, Agarwal ;
Oldham, William M. ;
Stephens, Thomas E. ;
Goldstein, Ronald H. ;
Waxman, Aaron B. ;
Tracy, Julie A. ;
Leary, Peter J. ;
Leopold, Jane A. ;
Kinlay, Scott ;
Opotowsky, Alexander R. ;
Systrom, David M. ;
Maron, Bradley A. .
PULMONARY CIRCULATION, 2015, 5 (04) :610-618
[10]   Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment [J].
Borlaug, Barry A. ;
Paulus, Walter J. .
EUROPEAN HEART JOURNAL, 2011, 32 (06) :670-+